Crcle Guaifensin Extended Release Tablet, 1200 mg 1200 mg/1
Guaifensin Extended-Release · TABLET · Innovus Pharmaceuticals, Inc.
Crcle Guaifensin Extended Release is an over-the-counter expectorant tablet that helps thin mucus to make coughs more productive when you have chest congestion. Each tablet contains 1200 mg of guaifenesin and is designed to provide extended relief.
Key Facts
- Brand Name
- Crcle Guaifensin Extended Release Tablet, 1200 mg
- Generic Name
- Guaifensin Extended-Release
- NDC Code (Product)
57483-280- Manufacturer
- Innovus Pharmaceuticals, Inc.
- Strength
- 1200 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA213420
- Drug Class
- Expectorant [EPC]
- Marketing Start
- 09/10/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Crcle Guaifensin Extended Release Tablet, 1200 mg used for?
Crcle Guaifensin Extended Release is an over-the-counter expectorant tablet that helps thin mucus to make coughs more productive when you have chest congestion. Each tablet contains 1200 mg of guaifenesin and is designed to provide extended relief.
Is Crcle Guaifensin Extended Release Tablet, 1200 mg a controlled substance?
Crcle Guaifensin Extended Release Tablet, 1200 mg is not classified as a controlled substance by the DEA.
What is the generic name for Crcle Guaifensin Extended Release Tablet, 1200 mg?
The generic name for Crcle Guaifensin Extended Release Tablet, 1200 mg is Guaifensin Extended-Release. There are no other listed brand versions of Guaifensin Extended-Release.
What is the NDC code for Crcle Guaifensin Extended Release Tablet, 1200 mg 1200 mg/1?
The NDC (National Drug Code) for Crcle Guaifensin Extended Release Tablet, 1200 mg 1200 mg/1 is 57483-280, listed by Innovus Pharmaceuticals, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)